![](/img/cover-not-exists.png)
Corrigendum to “A high-performance liquid chromatography-tandem mass spectrometry method for the analysis of lifirafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine, and its application in a clinical pharmacokinetic study” [J. Pharm. Biomed. Anal. 166 (2019) 20–29]
Yao, Xueting, Song, Ling, Liu, Yang, Wang, Huanhuan, Liu, Jie, Jiang, Ji, Liu, Dongyang, Hu, PeiLanguage:
english
Journal:
Journal of Pharmaceutical and Biomedical Analysis
DOI:
10.1016/j.jpba.2019.04.047
Date:
June, 2019
File:
PDF, 252 KB
english, 2019